The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
 
Prachi Bhave
Travel, Accommodations, Expenses - MSD
 
Angela M. Hong
Honoraria - Bayer
 
Rebecca Johnson
Honoraria - MSD
 
Alexander M. Menzies
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; QBiotics; Roche
 
Georgina V. Long
Consulting or Advisory Role - Aduro Biotech; Amgen; Array BioPharma; Boehringer Ingelheim; Bristol-Myers Squibb; Hexal; Highlight Therapeutics; Merck Sharpe & Dohme; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Skyline Diagnostics; Specialised Therapeutics
 
Joanna Mangana
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme; Merck/Pfizer; Novartis; Pierre Fabre; Sanofi
Research Funding - BMS (Inst); MSD (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; L'Oreal; Merck Sharp & Dohme; Pierre Fabre; Ultrasun
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Catalyst Pharmaceuticals; Iovance Biotherapeutics; Janssen; Merck; Novartis; Oncosec
Research Funding - Bristol-Myers Squibb; Incyte
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy
 
Zeynep Eroglu
Consulting or Advisory Role - Elsevier; Genentech/Roche; Natera; Novartis; OncoSec; Regeneron; Sun Pharma
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Ozgecan Dulgar
No Relationships to Disclose
 
Hui-Ling Yeoh
No Relationships to Disclose
 
Andrew Mark Haydon
Honoraria - Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Georg Lodde
Travel, Accommodations, Expenses - Sun Pharma
 
Elisabeth Livingstone
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Medac; Novartis; Sanofi; Sun Pharma; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medac; Pierre Fabre; Sun Pharma
 
Muhammad Adnan Khattak
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; MSD
 
Katharina C. Kähler
Consulting or Advisory Role - Aventis Pharma; Bristol-Myers Squibb; MSD; Novartis; Sanofi
Research Funding - MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Sun BioPharma
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Philogen; Regeneron; Replimune; Roche; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Philogen; Regeneron; Replimune; Roche; Sanofi/Aventis
Research Funding - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche; Sanofi/Aventis
 
Wei Wang
No Relationships to Disclose
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Merck Serono; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi